Katharina Pardon
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to "EPICYCLE: A confirmatory preclinical study of the anti-rhabdomyosarcoma efficacy of BET bromodomain and cyclin-dependent kinase 9 inhibitors" [Biomed. Pharmacother. 192 (2025), 118704].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 14, 2026
EPICYCLE: A confirmatory preclinical study of the anti-rhabdomyosarcoma efficacy of BET bromodomain and cyclin-dependent kinase 9 inhibitors.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 07, 2025
Oncogene Silencing via ecDNA Micronucleation.
Journal: bioRxiv : the preprint server for biology
Published: May 05, 2025
Selective Depletion of Cancer Cells with Extrachromosomal DNA via Lentiviral Infection.
Journal: Cancer research communications
Published: March 11, 2025
Selective depletion of cancer cells with extrachromosomal DNA via lentiviral infection.
Journal: bioRxiv : the preprint server for biology
Published: March 10, 2025
Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control.
Journal: Nature communications
Published: September 30, 2024
Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 04, 2022
Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 10, 2021
Senescence-associated reprogramming promotes cancer stemness.
Journal: Nature
Published: February 16, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026